Zanubrutinib versus bendamustine and rituximab in untreated patients with CLL/SLL Zanubrutinib versus bendamustine and rituximab in untreated patients with CLL/SLL February 2025 Clinical trials Read more
2021 June Science Intensified treatment for patients with early stage, unfavourable Hodgkin’s lymphoma Read more
2021 June Pharma News Salvage autologous transplant and lenalidomide maintenance versus lenalidomide/dexamethasone f... Read more
2021 June Clinical trials Addition of lenalidomide to r-chop improves outcomes in newly diagnosed diffuse large B-cell l... Read more
2021 June Clinical trials Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome–negative adu... Read more
2021 May Clinical practice Copanlisib plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma Read more
Top
